Previous 10 | Next 10 |
2023-04-26 16:36:34 ET Icon press release ( NASDAQ: ICLR ): Q1 Non-GAAP EPS of $2.90 beats by $0.03 . Revenue of $1.98B (+4.2% Y/Y) in-line. Net business wins in the quarter of $2,415 million; a net book to bill of 1.22. Closing backlog of $21.2 billion, an inc...
Highlights Net business wins in the quarter of $2,415 million; a net book to bill of 1.22. Closing backlog of $21.2 billion, an increase of 2.4% on quarter four 2022 or an increase of 8.4% on quarter one 2022. First quarter revenue of $1,978.6 million representing an increase of 4...
2023-04-25 17:35:57 ET Icon ( NASDAQ: ICLR ) is scheduled to announce Q1 earnings results on Wednesday, April 26th, after market close. The consensus EPS Estimate is $2.87 (+4.0% Y/Y) and the consensus Revenue Estimate is $1.98B (+4.2% Y/Y). Over the last 2 years, ICLR...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the first quarter 2023 after the market closes on Wednesday, April 26, 2023. The company will hold a conference call and webcas...
LEO Pharma , a global leader in medical dermatology, and ICON plc (NASDAQ: ICLR) today announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective, and which will support the company’s overall ambition...
2023-03-06 09:29:44 ET Summary One name particularly appealing in the healthcare space is ICON Public Limited Company, a CRO (Contract Research Organization) that has delivered sustained revenue growth. While the macroeconomic environment is still unclear, the outlook for ICON see...
ICON plc , (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the 2023 Citi Healthcare Conference on Thursday, March 2, 2023 at 2pm ET. Dr. Steve Cutler, CEO of ICON plc, wi...
ICON Public Limited Company (ICLR) Q4 2022 Earnings Conference Call February 23, 2023, 08:00 AM ET Company Participants Kate Haven - VP of IR Brendan Brennan - CFO Steve Cutler - CEO Conference Call Participants Sandy Draper - Guggenheim Justin Bowers -...
Icon press release ( NASDAQ: ICLR ): Q4 Non-GAAP EPS of $3.13 beats by $0.08 . Revenue of $1.96B (+3.7% Y/Y) in-line. For further details see: Icon Non-GAAP EPS of $3.13 beats by $0.08, revenue of $1.96B in-line
Highlights Net business wins in the quarter of $2,350 million; a net book to bill of 1.20. Full year net business wins of $9,450 million; a net book to bill of 1.22. Closing backlog in the quarter of $20.7 billion, an increase of 2.4% on quarter three 2022 or an increase of 8.7% on qu...
News, Short Squeeze, Breakout and More Instantly...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2024 after the market closes on Wednesday, July 24, 2024. The company will hold a conference call and webcas...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET. Any changes to this event and links...
2024-05-31 07:00:07 ET David Windley from Jefferies issued a price target of $390.00 for ICLR on 2024-05-31 05:48:00. The adjusted price target was set to $390.00. At the time of the announcement, ICLR was trading at $322.92. The overall price target consensus is at $265...